[Silent myocardial ischemia in hypertensive patients]

S Un1, T Mengden, K Glänzer

  • 1Medizinische Universitäts-Poliklinik, Bonn.

Praxis
|May 24, 2000
PubMed

Insights

Silent myocardial ischemia, common in hypertension, poses a significant risk. Detecting these silent events via ECG and blood pressure monitoring is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Ischemic Heart Disease

Context:

  • Silent myocardial ischemia affects approximately 35% of hypertensive individuals.
  • Ischemic events often occur without angina, remaining clinically silent.
  • Standard exercise ECG may miss events detectable by 24-hour Holter monitoring.

Purpose:

  • To highlight the prevalence and significance of silent myocardial ischemia in hypertensive patients.
  • To emphasize the diagnostic value of simultaneous ECG and blood pressure monitoring.
  • To underscore the prognostic implications of silent ischemia in hypertension.

Summary:

  • Silent myocardial ischemia, triggered by hypertensive peaks or heart rate increases, is prevalent in hypertensive individuals.
  • 24-hour Holter monitoring with simultaneous ST-triggered ECG and blood pressure recording is superior to exercise ECG for detecting silent ischemic events.
  • Silent ischemia indicates a higher risk, potentially worse than known coronary artery disease (CAD) in hypertensive patients without CAD.

Impact:

  • Objective ST-analysis of silent ischemia is vital for risk stratification in hypertensive patients.
  • Identifying silent ischemia necessitates its inclusion in therapeutic strategies, primarily antihypertensive treatment.
  • Effective management of silent ischemia can prevent adverse cardiovascular events and improve prognosis in hypertensive individuals.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...